CFDA issues Good Supply Practice for Pharmaceutical Products
The Good Supply Practice for Pharmaceutical Products (CFDA Order No. 13) was adopted at the executive meeting of China Food and Drug Administration (CFDA) on May 18, 2015, and was recently promulgated. It went into effect as of the date of promulgation. For more detailed, please visit Chinese version of notification: http://eng.sfda.gov.cn/WS03/CL0757/123382.html
